CalciMedica, Inc. — Form SCHEDULE 13D
Filed July 10, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D
— Neutral
significance 42/100
What the filing says
Alafi Capital Co LLC filed a Schedule 13D on July 10, 2026, disclosing acquisition of beneficial ownership in CalciMedica, Inc. The filing indicates a reportable position (typically ≥5% ownership threshold under securities law) but the specific share count, percentage owned, and purchase price/date are not disclosed in the header metadata provided. The joint filing agreement suggests coordinated action by multiple parties.
Why this rating
Schedule 13D is routine disclosure for 5%+ stakes. Without specific share count or % disclosed, cannot assess if transformational; relative to $15.7M market cap, a meaningful stake exists but magnitude unclear.
See more from July 10, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.